Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomidine in Bariatric Surgery
NCT06014359Unknown
- Sponsor
- Tanta University
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine (2 arms), sponsored by Tanta University. Primary endpoint: Hemodynamic response to laryngoscope, and pneumoperitoneum. Status: unknown.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT06014359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06014359.